RAPT Therapeutics in San Francisco, USA, relies on INTEGRA Biosciences’ pipettes to seamlessly accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory ...
Researchers at the Hackensack Meridian Center for Discovery and Innovation (CDI) are using the PIPETBOY GENIUS serological ...
Automating NGS sample preparation to accelerate microbiome research Microbiome research often involves complex workflows and ...
INTEGRA Biosciences reported a successful financial year in 2025, despite exceptional economic and geopolitical challenges. When adjusted for currency effects, the company achieved a solid growth of 3 ...
Conventional treatment options for patients diagnosed with solid cancers or autoimmune diseases are often limited or ineffective. Developing alternative treatments for these challenging conditions ...
Researchers at Purdue University are accelerating drug discovery for rare and neglected parasitic diseases using the WELLJET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results